Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography - A randomized trial

被引:266
作者
Brar, Somjot S. [1 ]
Shen, Albert Yuh-Jer [2 ,3 ]
Jorgensen, Michael B. [2 ,3 ]
Kotlewski, Adam [2 ]
Aharonian, Vicken J. [2 ]
Desai, Natasha [2 ]
Ree, Michael [2 ]
Shah, Ahmed Ijaz [2 ]
Burchette, Raoul J.
机构
[1] Columbia Univ, Med Ctr, Ctr Intervent Vasc Therapy, New York, NY 10032 USA
[2] Kaiser Permanente, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 300卷 / 09期
关键词
D O I
10.1001/jama.300.9.1038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Sodium bicarbonate has been suggested as a possible strategy for prevention of contrast medium - induced nephropathy, a common cause of renal failure associated with prolonged hospitalization, increased health care costs, and substantial morbidity and mortality. Objective To determine if sodium bicarbonate is superior to sodium chloride for preventing contrast medium - induced nephropathy in patients with moderate to severe chronic kidney dysfunction who are undergoing coronary angiography. Design, Setting, and Patients Randomized, controlled, single- blind study conducted between January 2, 2006, and January 31, 2007, and enrolling 353 patients with stable renal disease who were undergoing coronary angiography at a single US center. Included patients were 18 years or older and had an estimated glomerular filtration rate of 60 mL/ min per 1.73 m(2) or less and 1 or more of diabetes mellitus, history of congestive heart failure, hypertension, or age older than 75 years. Interventions Patients were randomized to receive either sodium chloride ( n= 178) or sodium bicarbonate ( n= 175) administered at the same rate ( 3 mL/ kg for 1 hour before coronary angiography, decreased to 1.5 mL/ kg per hour during the procedure and for 4 hours after the completion of the procedure). Main Outcome Measure The primary end point was a 25% or greater decrease in the estimated glomerular filtration rate on days 1 through 4 after contrast exposure. Results Median patient age was 71 ( interquartile range, 65- 76) years, and 45% had diabetes mellitus. The groups were well matched for baseline characteristics. The primary end point was met in 13.3% of the sodium bicarbonate group and 14.6% of the sodium chloride group ( relative risk, 0.94; 95% confidence interval, 0.55- 1.60; P=. 82). In patients randomized to receive sodium bicarbonate vs sodium chloride, the rates of death, dialysis, myocardial infarction, and cerebrovascular events did not differ significantly at 30 days ( 1.7% vs 1.7%, 0.6% vs 1.1%, 0.6% vs 0%, and 0% vs 2.2%, respectively) or at 30 days to 6 months ( 0.6% vs 2.3%, 0.6% vs 1.1%, 0.6% vs 2.3%, and 0.6% vs 1.7%, respectively) ( P >.10 for all). Conclusion The results of this study do not suggest that hydration with sodium bicarbonate is superior to hydration with sodium chloride for the prevention of contrast medium - induced nephropathy in patients with moderate to severe chronic kidney disease who are undergoing coronary angiography. Trial Registration clinicaltrials. gov Identifier: NCT00312117.
引用
收藏
页码:1038 / 1046
页数:9
相关论文
共 32 条
  • [1] Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin, P
    Aubry, P
    Fransson, S
    Strasser, R
    Willenbrock, R
    Berg, KJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) : 491 - 499
  • [2] EFFECT OF SODIUM-BICARBONATE PRELOADING ON ISCHEMIC RENAL-FAILURE
    ATKINS, JL
    [J]. NEPHRON, 1986, 44 (01): : 70 - 74
  • [3] Preventing nephropathy induced by contrast medium
    Barrett, BJ
    Parfrey, PS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) : 379 - 386
  • [4] Renal insufficiency following contrast media administration trial (REMEDIAL) - A randomized comparison of 3 preventive strategies
    Briguori, Carlo
    Airoldi, Flavio
    D'Andrea, Davide
    Bonizzoni, Erminio
    Morici, Nuccia
    Focaccio, Amelia
    Michev, Iassen
    Montorfano, Matteo
    Carlino, Mauro
    Cosgrave, John
    Ricciardelli, Bruno
    Colombo, Antonio
    [J]. CIRCULATION, 2007, 115 (10) : 1211 - 1217
  • [5] CAMPBELL DR, 1990, J CAN ASSOC RADIOL, V41, P133
  • [6] Bicarbonate inhibits N-nitrosation in oxygenated nitric oxide solutions
    Caulfield, JL
    Singh, SP
    Wishnok, JS
    Deen, WM
    Tannenbaum, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) : 25859 - 25863
  • [7] Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
    Dangas, G
    Iakovou, I
    Nikolsky, E
    Aymong, ED
    Mintz, GS
    Kipshidze, NN
    Lansky, AJ
    Moussa, I
    Stone, GW
    Moses, JW
    Leon, MB
    Mehran, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) : 13 - 19
  • [8] Iakovou Ioannis, 2003, J Invasive Cardiol, V15, P18
  • [9] Oxygen free radicals and contrast nephropathy
    Katholi, RE
    Woods, WT
    Taylor, GJ
    Deitrick, CL
    Womack, KA
    Katholi, CR
    McCann, WP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (01) : 64 - 71
  • [10] A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
    Levey, AS
    Bosch, JP
    Lewis, JB
    Greene, T
    Rogers, N
    Roth, D
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) : 461 - +